Osteologix, Inc. (OLGX.OB) Receives Positive Patent Decision for Key Osteoporosis Drug in Japan
Osteologix, Inc., a specialty biopharmaceutical company committed to improving the health of those afflicted with musculoskeletal diseases, yesterday announced that…